Page last updated: 2024-09-04

cyc 202 and sotalol

cyc 202 has been researched along with sotalol in 2 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(sotalol)
Trials
(sotalol)
Recent Studies (post-2010) (sotalol)
97973932,196346291

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)sotalol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)3.8169
Beta-1 adrenergic receptorHomo sapiens (human)7.1087
Beta-3 adrenergic receptorHomo sapiens (human)7.2
Beta-2 adrenergic receptorCanis lupus familiaris (dog)5.0667

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B1

Other Studies

2 other study(ies) available for cyc 202 and sotalol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10

    Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers

2012